Also, FoxM1 could enhance the TGF‐β1/Smad3 signalling in cancer cells by stabilizing Smad3/Smad4 complex and inhibiting Smad4 protein degradation induced by TIF1γ.16 This evidence concerns the gene TRIM33 and cancer.